{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:47:29Z","timestamp":1780519649184,"version":"3.54.1"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:p>With the intensifying global efforts to eradicate wild polioviruses, policymakers face complex decisions related to achieving eradication and managing posteradication risks. These decisions and the expanding use of inactivated poliovirus vaccine (IPV) trigger renewed interest in poliovirus immunity, particularly the role of mucosal immunity in the transmission of polioviruses. Sustained high population immunity to poliovirus transmission represents a key prerequisite to eradication, but poliovirus immunity and transmission remain poorly understood despite decades of studies. In April 2010, the U.S. Centers for Disease Control and Prevention convened an international group of experts on poliovirus immunology and virology to review the literature relevant for modeling poliovirus transmission, develop a consensus about related uncertainties, and identify research needs. This article synthesizes the quantitative assessments and research needs identified during the process. Limitations in the evidence from oral poliovirus vaccine (OPV) challenge studies and other relevant data led to differences in expert assessments, indicating the need for additional data, particularly in several priority areas for research: (1) the ability of IPV\u2010induced immunity to prevent or reduce excretion and affect transmission, (2) the impact of waning immunity on the probability and extent of poliovirus excretion, (3) the relationship between the concentration of poliovirus excreted and infectiousness to others in different settings, and (4) the relative role of fecal\u2010oral versus oropharyngeal transmission. This assessment of current knowledge supports the immediate conduct of additional studies to address the gaps.<\/jats:p>","DOI":"10.1111\/risa.12031","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T15:05:26Z","timestamp":1364483126000},"page":"606-646","source":"Crossref","is-referenced-by-count":69,"title":["Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs"],"prefix":"10.1111","volume":"33","author":[{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"first","affiliation":[{"name":"Kid Risk, Inc. 10524 Moss Park Rd. Ste. 204\u2010364 Orlando, FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases Division of Viral Diseases, Centers for Disease Control and Prevention Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin M.","family":"Chumakov","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research Food and Drug Administration Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal A.","family":"Halsey","sequence":"additional","affiliation":[{"name":"Department of International Health Johns Hopkins Bloomberg School of Public Health Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapani","family":"Hovi","sequence":"additional","affiliation":[{"name":"National Institute for Health and Welfare (THL) Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Minor","sequence":"additional","affiliation":[{"name":"National Institute of Biological Standards and Control Health Protection Agency, South Mimms, Potters Bar, Hertfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Modlin","sequence":"additional","affiliation":[{"name":"Dartmouth Medical School Hanover NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Patriarca","sequence":"additional","affiliation":[{"name":"Biologics Consulting Group, Inc. Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[{"name":"Polio Eradication Initiative World Health Organization Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Wright","sequence":"additional","affiliation":[{"name":"Dartmouth Medical School Hanover NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.F.","family":"Wassilak","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Center for Global Health Centers for Disease Control and Prevention Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Center for Global Health Centers for Disease Control and Prevention Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong\u2010Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc. 10524 Moss Park Rd. Ste. 204\u2010364 Orlando, FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc. 10524 Moss Park Rd. Ste. 204\u2010364 Orlando, FL USA"},{"name":"University of Central Florida College of Medicine Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"World Health Organization.Global Polio Eradication Initiative\u2013Strategy and work. Available at:http:\/\/www.polioeradication.org\/Resourcelibrary\/Strategyandwork.aspx Accessed on February 20 2013."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115547"},{"key":"e_1_2_9_4_1","article-title":"Polio Eradication Initiative. Cessation of Routine Oral Polio Vaccine (OPV) Use After Global Polio Eradication. Framework for National Policy Makers in OPV\u2010Using Countries","author":"World Health Organization","year":"2005","journal-title":"Geneva, Switzerland"},{"key":"e_1_2_9_5_1","volume-title":"Poliomyelitis: Mechanism for Management of Potential Risks to Eradication (Resolution 61.1)","author":"World Health Assembly","year":"2008"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12019"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"issue":"4","key":"e_1_2_9_8_1","first-page":"35","article-title":"Policy decision options during the first 5 years following certification of polio eradication","volume":"5","author":"Sangrujee N","year":"2003","journal-title":"Medscape General Medicine"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008820"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr399"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.48.9.1181"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/B978-1-4160-3611-1.50030-1","volume-title":"Vaccines","author":"Sutter RW","year":"2008"},{"issue":"4","key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1539-6924.2008.01078.x","article-title":"Uncertainty and sensitivity analyses of a decision analytic model for post\u2010eradication polio risk management","volume":"28","author":"Tebbens RJ","year":"2008","journal-title":"Risk Analysis"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.122192"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.001"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi206"},{"issue":"8","key":"e_1_2_9_19_1","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson KM","year":"2008","journal-title":"Medscape Journal of Medicine"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/sdr.419"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00841.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00843.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0025-5564(94)00046-3"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511662935.048"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01864.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2008.01098.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0272-4332.2005.00571.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.1992.tb01310.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2009.01325.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195064650.001.0001","volume-title":"Experts in Uncertainty: Opinion and Subjective Probability in Science","author":"Cooke RM","year":"1991"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S371"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq320"},{"key":"e_1_2_9_34_1","volume-title":"Vaccines","author":"Plotkin SA","year":"2008"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-0036-4_21"},{"key":"e_1_2_9_36_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious Diseases of Humans: Dynamics and Control","author":"Anderson RM","year":"1991"},{"key":"e_1_2_9_37_1","first-page":"265","article-title":"Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity","volume":"5","author":"Ghendon YZ","year":"1961","journal-title":"Acta Virologica"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054960"},{"key":"e_1_2_9_39_1","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk\u2010vaccinated children. A family study during a type 1 poliomyelitis epidemic","volume":"76","author":"Marine WM","year":"1962","journal-title":"American Journal of Hygiene"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00844.x"},{"issue":"2","key":"e_1_2_9_41_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.aje.a121058","article-title":"Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine","volume":"90","author":"Glezen PW","year":"1969","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"e_1_2_9_42_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/oxfordjournals.aje.a120578","article-title":"Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1","volume":"83","author":"Glezen WP","year":"1966","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"e_1_2_9_43_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.aje.a120529","article-title":"Oral poliovirus vaccination in middle income families","volume":"82","author":"Kogon A","year":"1965","journal-title":"American Journal of Epidemiology"},{"key":"e_1_2_9_44_1","first-page":"74","article-title":"The response and the lack of spread in Swedish school children given an attenuated poliovirus vaccine prepared in human diploid cell strain","volume":"79","author":"Pagano JS","year":"1964","journal-title":"American Journal of Hygiene"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92091-5"},{"issue":"1","key":"e_1_2_9_46_1","first-page":"27","article-title":"The elimination of polio in the Scandinavian countries","volume":"21","author":"B\u00f6ttiger M","year":"1993","journal-title":"Public Health Reviews"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S457"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90244-G"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.042"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.452"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/2.3.352"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"e_1_2_9_53_1","volume-title":"Transmissibility and Persistence of Oral Poliovirus Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative","author":"Fine PEM","year":"1998"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1086\/525049"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1769"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-12-3065"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.133"},{"key":"e_1_2_9_58_1","first-page":"215","article-title":"Vaccination with the chat strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination","volume":"22","author":"Plotkin SA","year":"1960","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_59_1","first-page":"294","volume-title":"2nd International Conference on Live Poliomyelitis Vaccines","author":"Plotkin SA","year":"1960"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61230-5"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X07311752"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Frisa.12031","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.12031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T03:14:11Z","timestamp":1715138051000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/risa.12031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1111\/risa.12031"],"URL":"https:\/\/doi.org\/10.1111\/risa.12031","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}